This study evaluates a comprehensive, patient-centered home-based care management program for patients with atypical Parkinsonian syndromes, focusing on improving quality of life, reducing hospitalizations, and optimizing functional independence. Atypical Parkinsonian syndromes (APS) represent a group of neurodegenerative disorders that share features with Parkinson's Disease but typically progress more rapidly and respond less favorably to dopaminergic medications[PSP_nih].
The trial addresses a critical gap in neurological care: while significant research focuses on disease-modifying therapies, there remains a substantial unmet need in optimizing day-to-day management of patients with progressive neurodegnerative conditions. The integrated care model recognizes that comprehensive support services can significantly impact patient outcomes even in the absence of curative treatments.
| Field |
Value |
| NCT ID |
NCT05792332 |
| Status |
Recruiting |
| Study Type |
Interventional |
| Study Design |
Parallel assignment, single-blind |
| Conditions |
PSP, MSA, CBS, Atypical Parkinsonism |
| Intervention |
Home-based comprehensive care management |
| Age Range |
18 years and older |
| Enrollment |
Target enrollment specified in trial registry |
| Primary Sponsor |
Academic medical center |
PSP is a rare neurodegenerative disorder characterized by:
- Vertical gaze palsy — difficulty moving eyes vertically
- Postural instability — early and frequent falls
- Parkinsonism — bradykinesia, rigidity
- Cognitive decline — frontal lobe dysfunction
Richardson syndrome (classic PSP) accounts for approximately 70% of cases, with other variants including:
- PSP with parkinsonism (PSP-P)
- PSP with pure akinesia and gait freezing (PSP-PAGF)
- PSP with corticobasal syndrome (PSP-CBS)
The Richardson variant typically progresses more rapidly, with patients often requiring mobility aids within 3-4 years of onset and nursing home placement within 5-7 years.
MSA encompasses two main subtypes:
- MSA-P (predominantly parkinsonian): Features include parkinsonism, autonomic dysfunction
- MSA-C (predominantly cerebellar): Features include ataxia, cerebellar signs
Key distinguishing features include:
- Autonomic failure — orthostatic hypotension, urinary dysfunction
- Cerebellar signs — gait ataxia, nystagmus
- Parkinsonism — poor levodopa response
- Rapid progression — typically 5-9 years from onset to death
Approximately 55% of cases present as MSA-P and 45% as MSA-C, with autonomic dysfunction being a defining feature.
CBS represents a heterogeneous disorder with:
- Asymmetric parkinsonism — typically affects one side initially
- Cortical sensory loss — astereognosis, neglect
- Apraxia — difficulty with learned motor tasks
- Alien limb phenomena — involuntary limb movements
- Cognitive decline — progressive aphasia, executive dysfunction
CBS can arise from multiple underlying pathologies including corticobasal degeneration, progressive supranuclear palsy, Alzheimer's disease, and frontotemporal lobar degeneration, making accurate diagnosis challenging[cbs_Overview].
Atypical Parkinsonian syndromes (APS) present unique challenges that differ substantially from Parkinson's Disease:
- Rapid progression: Mean survival 5-8 years from diagnosis, versus 15-20 years in PD
- Early disability: Loss of ambulation typically occurs within 3-5 years
- Multisystem involvement: Motor, autonomic, cognitive, and behavioral symptoms
- Poor medication response: Limited benefit from levodopa compared to PD
- Complex regimens: Multiple medications for various symptoms
- Adverse effects: Sensitivity to medications, particularly antipsychotics
- Complex care coordination: Multiple specialists (neurology, cardiology, urology, psychiatry)
- Equipment needs: Mobility aids, communication devices, home modifications
- 24-hour supervision: Progressive need for caregiver assistance
The comprehensive care model addresses multiple challenges[integrated_care_neuro][caregiver_burden]:
-
Complex medication regimens
- Multiple daily medications for motor and non-motor symptoms
- Timing dependencies (levodopa dosing intervals)
- Drug interactions requiring careful management
- Financial burden of multiple medications
-
Multiple specialist appointments
- Coordination across multiple healthcare systems
- Transportation challenges as disease progresses
- Communication between providers
- Appointment scheduling complexity
-
Progressive functional decline
- Loss of independence in activities of daily living
- Fall risk increasing with disease progression
- Communication difficulties
- Swallowing and nutrition challenges
-
High caregiver burden
- Physical demands of assistance with daily activities
- Emotional and psychological stress
- Financial burden of care-related costs
- Social isolation and role changes
-
Risk of institutionalization
- Caregiver burnout leading to nursing home placement
- Medical crises requiring hospitalization
- Safety concerns at home
- Financial considerations
Evidence supports the efficacy of integrated care approaches[integrated_care_neuro][telehealth_neuro]:
-
Coordination across disciplines
- Multidisciplinary team approach
- Unified care planning
- Shared decision-making
-
Home-based interventions
- In-home therapy services
- Environmental modifications
- Personalized care plans
-
Telehealth monitoring
- Remote symptom tracking
- Medication adherence support
- Virtual check-ins
-
Caregiver support
- Education and training
- Respite services
- Support groups
-
Proactive problem-solving
- Anticipatory guidance
- Early intervention for complications
- Advance care planning
The trial measures several key outcomes:
-
Quality of life measures
- PDQ-39 (Parkinson's Disease Questionnaire-39)
- Caregiver burden scales (Zarit Burden Interview)
- Health utility measures
-
Healthcare utilization
- Hospitalization rates and frequency
- Emergency department visits
- Outpatient visit patterns
-
Safety outcomes
- Falls frequency and severity
- Time to first fall
- Fall-related injuries
-
Treatment adherence
- Medication compliance rates
- Appointment attendance
- Protocol adherence
Secondary outcomes include[home_rehab][fall_prevention]:
-
Functional independence
- ADL (Activities of Daily Living) scores
- IADL (Instrumental ADL) measures
- Functional Independence Measure (FIM)
-
Care trajectory
- Time to institutionalization
- Progression to wheelchair dependence
- Development of new complications
-
Patient and caregiver satisfaction
- Satisfaction questionnaires
- Quality of care measures
- Care experience ratings
-
Health economics
- Cost-effectiveness analysis
- Healthcare cost comparison
- Resource utilization patterns
The care coordination component provides:
Home safety interventions include[fall_prevention]:
Technology-enabled monitoring provides[telehealth_neuro]:
-
Vital sign tracking
- Blood pressure monitoring (critical for MSA)
- Heart rate variability
- Weight monitoring
-
Symptom reporting
- Motor symptom tracking
- Non-motor symptom logs
- Side effect documentation
-
Medication reminders
- Automated dosing reminders
- Refill notifications
- Compliance tracking
-
Exercise compliance
- Home exercise program monitoring
- Physical therapy adherence
- Daily activity tracking
¶ 4. Education and Support
Patient and caregiver education covers:
-
Disease education
- Understanding disease progression
- Symptom management strategies
- Medication knowledge
-
Coping strategies
- Behavioral management techniques
- Stress reduction methods
- Communication strategies
-
Advance care planning
- Goals of care discussions
- Advance directive completion
- Legal planning (power of attorney, living will)
-
Support groups
- Patient support groups
- Caregiver support networks
- Community resources
PSP patients particularly benefit from integrated care because[psp_nih]:
-
Early falls require immediate home safety interventions
- Environmental modifications prevent injuries
- Mobility aids preserve independence
- Caregiver training enables safe assistance
-
Progressive disability needs anticipatory planning
- Equipment needs evolve as disease progresses
- Care needs increase over time
- Financial planning addresses long-term needs
-
Cognitive changes affect treatment adherence
- Caregiver involvement ensures compliance
- Simplified medication regimens improve adherence
- Regular monitoring identifies issues early
-
Caregiver support is essential
- High burden requires proactive support
- Respite prevents burnout
- Education improves care quality
MSA patients benefit from[msa_Overview]:
CBS patients require[cbs_Overview]:
-
Asymmetric care needs
- Equipment adapted to affected side
- Environmental modifications for unilateral deficits
-
Communication support
- Augmentative communication devices
- Speech therapy integration
-
Cognitive support
- Structured daily routines
- Environmental cues
- Behavioral management strategies
The integrated care model anticipates[integrated_care_neuro][caregiver_burden]:
-
Reduced healthcare utilization
- Fewer emergency department visits
- Reduced hospitalization rates
- Shorter hospital stays when required
-
Improved quality of life
- Better symptom management
- Enhanced functional independence
- Improved psychological well-being
-
Delayed institutionalization
- Extended time at home
- Reduced nursing home placement
- Caregiver sustainability improved
-
Reduced caregiver burden
- Improved coping skills
- Better support systems
- Enhanced quality of life
-
Cost savings
- Reduced healthcare costs
- Delayed long-term care expenses
- Optimized resource utilization
¶ Comparison with Standard Care
| Outcome |
Standard Care |
Integrated Care |
| Annual hospitalizations |
2-3 per year |
Expected reduction |
| Fall rate |
60-70% annually |
Expected reduction |
| Time to nursing home |
3-5 years |
Expected extension |
| Caregiver burden |
High |
Moderate |
| Quality of life |
Variable |
Expected improvement |
- Care coordinators (1:30 patient ratio)
- Physical therapists for home assessments
- Telehealth support staff
- Administrative support
- Video conferencing platform (HIPAA-compliant)
- Remote monitoring devices
- Electronic health record integration
- Patient portal access
- Initial investment in infrastructure
- Staff training and development
- Ongoing operational costs
- Reimbursement models
This trial will inform:
- Policy development for APS care standards
- Reimbursement models for integrated care
- Quality measures for neurological care
- Care pathway development for APS management